Clonal Plasma Cell Pathophysiology and Clinical Features of Disease Are Linked to Clonal Plasma Cell Expression of Cyclin D1 in Systemic Light-Chain Amyloidosis-Reference-Cited by-同舟云学术

Clonal Plasma Cell Pathophysiology and Clinical Features of Disease Are Linked to Clonal Plasma Cell Expression of Cyclin D1 in Systemic Light-Chain Amyloidosis

Published:2012-02 Issue:1 Volume:12 Page:49-58
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Zhou Ping,Hoffman James,Landau Heather,Hassoun Hani,Iyer Lakshmanan,Comenzo Raymond L.

Funder

NIH

FDA

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Molecular mechanisms of amyloidosis;Merlini;N Engl J Med,2003

2. Multicentre versus single centre approach to rare diseases: the model of systemic light chain amyloidosis;Palladini;Amyloid,2005

3. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma;Bergsagel;Blood,2005

4. The enigmatic role of cyclin D1 in multiple myeloma;Lesage;Int J Cancer,2005

5. Initial genome sequencing and analysis of multiple myeloma;Chapman;Nature,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma;Journal of Clinical Medicine;2023-02-17

2. AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies;JACC: CardioOncology;2021-10

3. Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications;Experimental Hematology & Oncology;2021-07-20

4. Use of biomarkers to diagnose and manage cardiac amyloidosis;European Journal of Heart Failure;2021-02

5. Systemic Amyloidosis Due to Clonal Plasma Cell Diseases;Hematology/Oncology Clinics of North America;2020-12